Guides
Startup of the month, Aspect Biosystems: bioprinting human tissues
Our startup of the month is Aspect Biosystems, a Canadian specialist in bioprinting. Aspect Biosystems has developed a unique technology that allows the creation of customized human tissues for different applications such as drug development, regenerative medicine, disease unders
- 3 min read
- Guides
- Six more stories

Our startup of the month is Aspect Biosystems, a Canadian specialist in bioprinting. Aspect Biosystems has developed a unique technology that allows the creation of customized human tissues for different applications such as drug development, regenerative medicine, disease understanding, etc. At the intersection of biology, medicine, and engineering, Aspect Biosystems wants to revolutionize bioprinting, a branch of additive manufacturing that could already become the future of medicine. We met with Sam Wadsworth, Co-Founder and Chief Scientific Officer, to learn more about this ambitious startup.
3DN: Can you introduce us to Aspect Biosystems?
Aspect Biosystems began as a spin-off company from the University of British Columbia in Vancouver, Canada. Created in 2013 by 4 academic researchers, Aspect’s technology is based on more than 10 years of research and development and is based on interdisciplinary collaborations between medical and engineering research groups.

Sam Wadsworth
3DN: Aspect Biosystems has developed a new bioprinting technology, Lab-on-a-Printer. Can you tell us more about it?
Aspect has used various concepts of 3D printing, lab-on-a-chip, and CAD to create one of the most advanced bioprinting technologies to date. Aspects’ Lab-on-a-Printer™ platform is a brand-new way of bioprinting, designed specifically to manufacture physiologically complex human tissues for various applications in the life sciences.





